These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Iridium(iii) complexes as mitochondrial topoisomerase inhibitors against cisplatin-resistant cancer cells.
    Author: He L, Xiong K, Wang L, Guan R, Chen Y, Ji L, Chao H.
    Journal: Chem Commun (Camb); 2021 Aug 28; 57(67):8308-8311. PubMed ID: 34319315.
    Abstract:
    Herein, we developed the first metal-based mitochondrial topoisomerase inhibitors to achieve an effective therapeutic outcome for the therapy of cisplatin-resistant tumour cells.
    [Abstract] [Full Text] [Related] [New Search]